Ignite Creation Date:
2024-05-06 @ 7:18 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05965362
Status:
RECRUITING
Last Update Posted:
2024-07-12
First Post:
2023-02-14
Brief Title:
Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers ENDEAVOR
Sponsor:
First Affiliated Hospital Xian Jiaotong University
Organization:
First Affiliated Hospital Xian Jiaotong University
Study Overview
Official Title:
Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers ENDEAVOR a National Multi-center Retrospective-prospective Cohort Study Initiated by the Investigators
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ENDEAVOR
Brief Summary:
In this study by establishing a clinical cohort of infective endocarditis we observed the natural prognosis and influencing factors in the process of disease development and regression we used multi-omics technology to understand the prognostic value of its biomarkers and provided new ideas and evidence for the pathogenesis clinical diagnosis and treatment of IE
Detailed Description:
Infective endocarditis is an inflammation of the inner lining of the heart valves or ventricular walls caused by direct infection of the heart by bacteria fungi and other microorganisms via the bloodstream route At present the clinical diagnosis of IE is mainly based on a combination of typical symptoms imaging and blood culture etc Finding more sensitive means and more accurate indicators for early detection of IE flora distribution characteristics is of great significance for the prevention and targeted treatment of IE Therefore in this study by establishing a clinical cohort of infective endocarditis we observed the natural prognosis and influencing factors in the process of disease development and regression we used multi-omics technology to understand the prognostic value of its biomarkers and provided new ideas and evidence for the pathogenesis clinical diagnosis and treatment of IE
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None